See also this year's filing and all EDGAR filings for this company.
PDF Report 0001579428_2017_Axsome_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001579428')"} |
Graph
Absolute values for 0001579428, Axsome Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 37,999,057 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 100,730 |
| 3 | remainder_Assets | 112,821 |
| 4 | LiabilitiesCurrent | 7,170,712 |
| 5 | LiabilitiesNoncurrent | 9,470,445 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,343,648 |
| 9 | ResearchAndDevelopmentExpense | 21,199,860 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 341,855 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 38,212,608 |
| 1 | Liabilities | 16,641,157 |
| 2 | Expenses | 27,543,508 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 21,571,451 |
| 5 | NetIncome | -27,201,653 |
| 6 | ComprehensiveNetIncome | -27,201,653 |
| 7 | BaseVar | 41,369,564 |
| 8 | EconomicCapitalRatio | 0.361 |